Rosalba D'Alessandro

7PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersTumour immunologyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 27, 2026
RETRACTED: Refolo et al. Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells. Int. J. Mol. Sci. 2018, 19, 1518.

Maria Grazia Refolo, Catia Lippolis, Nicola Carella

|Apr 26, 2025
Unravelling Paclitaxel Resistance in Gastric Cancer: The Role of Small Extracellular Vesicles in Epithelial Mesenchymal Transition and Extracellular Matrix Remodelling.

Giorgia Panzetta, Annalisa Schirizzi, Francesco Balestra

|Jan 08, 2025
Circulating miR-23b-3p, miR-30e-3p, and miR-205-5p as Novel Predictive Biomarkers for Ramucirumab-Paclitaxel Therapy Outcomes in Advanced Gastric Cancer.

Emanuele Piccinno, Annalisa Schirizzi, Viviana Scalavino

|Oct 26, 2024
Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications.

Angela Dalia Ricci, Alessandro Rizzo, Annalisa Schirizzi

|Jul 27, 2024
Autotaxin-Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications.

Carmelo Laface, Angela Dalia Ricci, Simona Vallarelli

|Oct 28, 2023
VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment.

Annalisa Schirizzi, Aram Arshadi, Doron Tolomeo

Pageof 2

Frequent Collaborators

4 joint publications

Gianluigi Giannelli

4 joint publications

Claudio Lotesoriere

2 joint publications

Rossella Donghia

2 joint publications

Caterina Messa